MAQUET Cardiovascular LLC Company Profile

04:21 EST 22nd November 2017 | BioPortfolio

Patients with vascular conditions require flexible treatment options, including both traditional open vascular interventions and endovascular therapies. Current research indicates that surgeons use a balance of open and endovascular therapies depending on the patient's needs and condition. Traditional open vascular interventions are often used to repair ruptured, occluded or atypical vessels that have a bend or kink that are not well-served by endovascular options. MAQUET offers clinicians a full range of vascular surgical implants to meet each patient's needs.

News Articles [443 Associated News Articles listed on BioPortfolio]

Maquet recalls intra-aortic balloon pumps

Maquet has issued a Class I recall on more than 5,000 intra-aortic balloon pumps (IABPs) in the United States due to a false blood detection alarm and the entrance of fluid into the devices. The IABP...

Takeda, Cardurion Pharmaceuticals partner on cardiovascular development

Takeda Pharmaceutical and Cardurion Pharmaceuticals announced the creation of a new cardiovascular development partnership. Cardurion, a recently launched Boston-area based biotechnology company, is f...

Pericardial fat—not liver fat—associated with higher cardiovascular disease risk

Fat surrounding the

AUM Cardiovascular receives FDA clearance for diagnostic ECG system

AUM Cardiovascular has received clearance from the Food and Drug Administration (FDA) for its non-invasive acoustic and ECG device. The CADence device uses recorded sounds from a patient's heart and p...

One year results from the REDUCE trial reported at TCT 2017

(Cardiovascular Research Foundation) Results from the prospective, multicenter, randomized investigator-initiated REDUCE trial were reported today at the 29th annual Transcatheter Cardiovascular Thera...

Announcing the TCT 2017 press conference schedule

(Cardiovascular Research Foundation) The Cardiovascular Research Foundation (CRF) has announced the press conference schedule for late-breaking trials and first report investigations that will be pres...

Canagliflozin Reduces Cardiovascular Events in Diabetic Patients

Canagliflozin resulted in a lower risk of cardiovascular disease in type 2 diabetics who were at high cardiovascular risk. However, there was a higher risk of amputation, which is a new finding.

A Rivaroxaban/Daily Low-dose Aspirin Combination and Cardiovascular Events

The addition of rivaroxaban to daily low-dose aspirin resulted in fewer cardiovascular outcomes and increased major bleeding compared to aspirin alone in patients with stable cardiovascular disease.

PubMed Articles [1714 Associated PubMed Articles listed on BioPortfolio]

Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.

The need for novel approaches to cardiovascular drug development served as the impetus to convene an open meeting of experts from the pharmaceutical industry and academia to assess the challenges and ...

Cardiovascular Disease in Korean Americans: A Systematic Review.

Despite Korean Americans being one of the fastest growing immigrant groups in the United States, little is known about their cardiovascular health or cardiovascular disease risk factors.

Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI).

To develop a document by Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI) to review and summarize the most recent evidences about the no...

Cardiovascular Effects of Antidiabetic Therapies.

Type 2- diabetes mellitus (T2DM) represents a major risk factor for cardiovascular complications and mortality. Strict glucose control in the early course of the disease prevents cardiovascular compli...

A Systematic Review of Interventions to Improve Health Factors or Behaviors of the Cardiovascular Health of Prisoners During Incarceration.

Prisoners are disproportionately affected by cardiovascular disease and its risk factors. However, primary prevention of cardiovascular disease in correctional settings has been widely neglected, and ...

Clinical Trials [2443 Associated Clinical Trials listed on BioPortfolio]

Neurally Adjusted Ventilatory Assist (NAVA) in Pediatric Patients

The purpose of this study is to find out if NAVA-technology is better in detecting patients own inspiratory efforts during mechanical ventilation than currently used flow-triggering in PRV...

Modified Ultrafiltration in Cardiac Surgery

The purpose of this study is to find out, whether filtration of the blood in patients undergoing cardiac surgery, beneficially influences the coagulation system.

Venovenous CO2 Removal in Patients With COPD and Acute Respiratory Failure

The purpose of this study to determine the safety and effectiveness of a mechanical device to remove carbon dioxide from the blood of patients with chronic obstructive pulmonary disease (C...

Factors Influencing Cardiovascular Prognosis

The purpose of this study is to identify risks for cardiovascular events in a follow up period of 10 years.

Work Organization and Cardiovascular Disease

To determine the combined effects of job strain and social isolation on cardiovascular morbidity and mortality.

Companies [592 Associated Companies listed on BioPortfolio]

MAQUET Cardiovascular, LLC

MAQUET has a long history of innovation in developing vascular grafts. Its signature products are the HEMASHIELD line of vascular grafts used for surgical repair of aneurysms and occluded arteries. HE...

MAQUET Cardiovascular LLC

Patients with vascular conditions require flexible treatment options, including both traditional open vascular interventions and endovascular therapies. Current research indicates that surgeons use a ...


MAQUET offers complete medical technology solutions for operating theatres and intensive care units,guaranteeing optimum treatement for patients and greatest-possible working comfort for personnel.

Getinge Infection Control AB

Getinge Group is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. We operate under...

Cardiovascular Consultants, Ltd.

Cardiovascular Consultants, Ltd., founded in 1986 by Dr. Andrei Damian, is dedicated to providing patients in Phoenix and surrounding areas with the most advanced and appropriate ...

More Information about "MAQUET Cardiovascular LLC" on BioPortfolio

We have published hundreds of MAQUET Cardiovascular LLC news stories on BioPortfolio along with dozens of MAQUET Cardiovascular LLC Clinical Trials and PubMed Articles about MAQUET Cardiovascular LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MAQUET Cardiovascular LLC Companies in our database. You can also find out about relevant MAQUET Cardiovascular LLC Drugs and Medications on this site too.

Quick Search

Relevant Topic

Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Corporate Database Quicklinks

Searches Linking to this Company Record